ROS1 and non-small cell lung carcinoma: Activating fusions and rearrangement of the proto-oncogene ROS-1 (c-ros oncogene 1) have been reported in 1–2% of NSCLC cases as potent oncogenic drivers, often found in non-smokers and patients of younger age [3].